-
[({[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy]phosphonic acid; bis(cyclohexanamine)
-
ChemBase ID:
155525
-
Molecular Formular:
C22H41N7O10P2
-
Molecular Mass:
625.549362
-
Monoisotopic Mass:
625.23901381
-
SMILES and InChIs
SMILES:
c1nc(c2c(n1)n(cn2)[C@H]1[C@@H]([C@@H]([C@H](O1)COP(=O)(O)OP(=O)(O)O)O)O)N.C1CCC(CC1)N.C1CCC(CC1)N
Canonical SMILES:
O[C@@H]1[C@@H](COP(=O)(OP(=O)(O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N.NC1CCCCC1.NC1CCCCC1
InChI:
InChI=1S/C10H15N5O10P2.2C6H13N/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(17)6(16)4(24-10)1-23-27(21,22)25-26(18,19)20;2*7-6-4-2-1-3-5-6/h2-4,6-7,10,16-17H,1H2,(H,21,22)(H2,11,12,13)(H2,18,19,20);2*6H,1-5,7H2/t4-,6-,7-,10-;;/m1../s1
InChIKey:
SCOUEIPNDLFPCX-IDIVVRGQSA-N
-
Cite this record
CBID:155525 http://www.chembase.cn/molecule-155525.html
NAMES AND DATABASE IDS
NAMES AND DATABASE IDS
Names Database IDs
IUPAC name
|
[({[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy]phosphonic acid; bis(cyclohexanamine)
|
|
|
IUPAC Traditional name
|
bis(cyclohexylamine) adenosine-diphosphate
|
|
|
Synonyms
|
ADP
|
Adenosine 5′-diphosphate bis(cyclohexylammonium) salt
|
腺苷-5′-二磷酸 双环己铵盐
|
|
|
CAS Number
|
|
MDL Number
|
|
PubChem SID
|
|
PubChem CID
|
|
DATA SOURCES
DATA SOURCES
All Sources Commercial Sources Non-commercial Sources
CALCULATED PROPERTIES
CALCULATED PROPERTIES
JChem
Acid pKa
|
1.7714787
|
H Acceptors
|
12
|
H Donor
|
6
|
LogD (pH = 5.5)
|
-7.1348915
|
LogD (pH = 7.4)
|
-7.671735
|
Log P
|
-4.982523
|
Molar Refractivity
|
84.9414 cm3
|
Polarizability
|
33.853855 Å3
|
Polar Surface Area
|
232.6 Å2
|
Rotatable Bonds
|
6
|
Lipinski's Rule of Five
|
false
|
DETAILS
DETAILS
Sigma Aldrich
Sigma Aldrich -
A4386
|
Caution Stable, non-hygroscopic Application Adenosine 5′-diphosphate (ADP) is an adenine nucleotide involved in energy storage and nucleic acid metabolism via its conversion into ATP by ATP synthases. ADP affects platelet activation through its interaction with ADP receptors P2Y1, P2Y12 and P2X1. Upon its conversion to adenosine by ecto-ADPases, platelet activation is inhibited via adenosine receptors. |
PATENTS
PATENTS
PubChem Patent
Google Patent